Disclosure Statement The Hawkins Foundation Greenville Hospital System DJO Surgical Tornier Cannon Breg Arthrocare Euflexxa OttoBach Smith & Nephew
Disclosure Statement Jason Folk, MD Consultant for Smith&Nephew Endoscopy
Product: Tumor Necrosis Factor alpha inhibitors (class drugs) examples below as reported in peer reviewed Rheumatology literature case studies Unlabeled use: Pigmented Villonodular Synovitis refractory to Surgery Disclosure Statement: Product / Unlabeled Use Discussion Dr. Steven Sabo Product: etanercept (Enbrel) and infliximab (Remicade) Unlabeled use: Pigmented Villonodular Synovitis refractory to Surgery Product: adalimumab (Humira) Unlabeled use: Pigmented Villonodular Synovitis refractory to Surgery
Disclosure Statement All other speakers/planners have no financial relationships to disclose
Clinical Track Planning Committee Kyle Cassas, MD, FACSM (Chair) Franklin Sease, MD (Vice Chair) Chad Asplund, MD Kenneth Barnes, MD Sean Bryan, MD Dave Sealy, MD Heather Fullerton, MD Rob Hosey, MD Charles Lascano, MD
Please thank our exhibitors and clinical track supporters who make this meeting possible! Please put your mobile devices on vibrate or silent mode.
We need your email address to mail out certificates after the meeting. CEU’s may also be available this year.
Thanks to Cecilia Hanna and the Hawkins Foundation for providing CME.
Clinical Reception will be held in River Terrace 2 Friday-6:30-8:00pm Presented by the Steadman Hawkins Clinic of the Carolinas